Literature DB >> 24079776

Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials.

Yuki Matsuda1, Taro Kishi, Nakao Iwata.   

Abstract

Entities:  

Keywords:  Amantadine; Efficacy; Memantine; Meta-analysis; NMDA receptor antagonists; Tolerability

Mesh：

Substances：

Year:  2013        PMID： 24079776     DOI： 10.1016/j.jpsychires.2013.09.002

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN： 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  8 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 2.  Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.

Authors:  Joshua T Kantrowitz; Neal R Swerdlow; Walter Dunn; Sophia Vinogradov
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

3.  Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.

Authors:  Gregory A Light; Wen Zhang; Yash B Joshi; Savita Bhakta; Jo A Talledo; Neal R Swerdlow
Journal:  Neuropsychopharmacology       Date:  2017-04-20       Impact factor: 7.853

4.  Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.

Authors:  Taro Kishi; Yuki Matsuda; Nakao Iwata
Journal:  Psychopharmacology (Berl)       Date:  2017-05-15       Impact factor: 4.530

Review 5.  Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.

Authors:  Qiongqiong Wu; Jing Huang; Renrong Wu
Journal:  Front Neurosci       Date:  2021-04-12       Impact factor: 4.677

6.  Tackling negative symptoms of schizophrenia with memantine.

Authors:  Antonios Paraschakis
Journal:  Case Rep Psychiatry       Date:  2014-04-10

Review 7.  Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?

Authors:  Tetsuro Kikuchi
Journal:  Biomolecules       Date:  2020-07-31

Review 8.  Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.

Authors:  Qiongqiong Wu; Xiaoyi Wang; Ying Wang; Yu-Jun Long; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Neurosci Bull       Date:  2021-07-05       Impact factor: 5.203
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.